Verve Therapeutics: Q4 Earnings Insights

Verve Therapeutics VERV reported its Q4 earnings results on Tuesday, February 27, 2024 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Verve Therapeutics beat estimated earnings by 16.0%, reporting an EPS of $-0.69 versus an estimate of $-0.82.

Revenue was up $4.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.2 which was followed by a 10.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Verve Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.